Korro Bio Inc [KRRO] stock is trading at $6.28, up 4.84%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The KRRO shares have gain 3.46% over the last week, with a monthly amount drifted -83.25%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Korro Bio Inc [NASDAQ: KRRO] stock has seen the most recent analyst activity on November 13, 2025, when William Blair downgraded its rating to a Mkt Perform. Previously, RBC Capital Mkts downgraded its rating to Sector Perform on November 13, 2025, and kept the price target unchanged to $8. On November 13, 2025, downgrade downgraded it’s rating to Mkt Perform. Piper Sandler downgraded its rating to a Neutral but stick to its price target of $11 on November 13, 2025. H.C. Wainwright downgraded its rating to a Neutral. Chardan Capital Markets downgraded its rating to Neutral for this stock on November 13, 2025, but kept the price target unchanged to $7. In a note dated November 13, 2025, Cantor Fitzgerald downgraded a Neutral rating on this stock.
Korro Bio Inc [KRRO] stock has fluctuated between $5.70 and $56.69 over the past year. Currently, Wall Street analysts expect the stock to reach $91.25 within the next 12 months. Korro Bio Inc [NASDAQ: KRRO] shares were valued at $6.28 at the most recent close of the market. An investor can expect a potential return of 1353.03% based on the average KRRO price forecast.
Analyzing the KRRO fundamentals
Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at -15.69%, Pretax Profit Margin comes in at -14.53%, and Net Profit Margin reading is -14.54%. To continue investigating profitability, this company’s Return on Assets is posted at -0.51, Equity is -0.62 and Total Capital is -0.6. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.39.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.02 points at the first support level, and at 5.75 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.46, and for the 2nd resistance point, it is at 6.64.
Ratios To Look Out For
For context, Korro Bio Inc’s Current Ratio is 6.71. Also, the Quick Ratio is 6.71, while the Cash Ratio stands at 1.96. Considering the valuation of this stock, the price to sales ratio is 8.02, the price to book ratio is 0.60.
